The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 222.00
Bid: 221.50
Ask: 222.50
Change: -1.00 (-0.45%)
Spread: 1.00 (0.451%)
Open: 220.00
High: 224.00
Low: 220.00
Prev. Close: 223.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: European large-caps rise on eve of Fed decision

Tue, 19th Mar 2024 16:57

(Alliance News) - Blue-chip stock prices in Europe closed higher on Tuesday, showing little signs of nerves ahead of Wednesday's Federal Reserve decision and UK inflation reading.

A key week for central bank decisions kicked off with a historic hike by the Bank of Japan, though that failed to spur on the yen.

The FTSE 100 index rose 15.75 points, 0.2%, at 7,738.30. The FTSE 250 ended down 53.72 points, 0.3%, at 19,432.81, and the AIM All-Share fell 1.07 points, 0.2%, at 735.56.

The Cboe UK 100 rose 0.2% to 774.76, the Cboe UK 250 fell 0.3% to 16,869.44, and the Cboe Small Companies closed up 0.3% at 14,818.14.

In European equities on Tuesday, the CAC 40 in Paris ended up 0.7%, while the DAX 40 in Frankfurt added 0.3%.

In New York, the Dow Jones Industrial Average was up 0.6% at the time of the closing bell in Europe. The S&P 500 rose 0.2%, though the Nasdaq Composite was fractionally lower.

The pound was quoted at USD1.2719 at the time of the London equities close, a touch lower from USD1.2722 on Monday. The euro stood at USD1.0860, down against USD1.0877.

The US Federal Reserve is expected to once again leave interest rates unmoved on Wednesday, while also dialling back cut expectations in its latest dot-plot.

The US central bank announces its latest interest rate decision at 1800 GMT on Wednesday. A press conference with Chair Jerome Powell follows shortly after. Threatening to hog the spotlight, the latest summary of economic projections will be revealed alongside the decision. The SEP features the dot-plot of interest rate expectations of policymakers.

In December, the chart suggested the Fed will enact three cuts this year.

With the CME FedWatch Tool suggesting a 99% chance the central bank holds in March, a 93% likelihood it does the same in May, and hope of a June cut dwindling, the December plot could be hawkishly re-jigged.

"The US data continue to come in mostly firmer and despite Powell's recent dovish testimony before Congress, most Fed officials remain very cautious about easing too soon. We believe that the current market easing expectations for the Fed still need to adjust. When they do, the dollar should gain further. Last week's inflation data sparked the start of this process and the FOMC decision tomorrow will be key for the continuation of this move," Brown Brothers Harriman analysts commented.

The Bank of England will also be in focus this week, with a UK inflation reading to come on Wednesday, the eve of Threadneedle Street's interest rate decision.

Ebury analyst Matthew Ryan commented: "Data on both UK inflation and wages has surprised to the downside since the last meeting, although both remain far too high for comfort and insufficient to warrant a change in guidance. There will be no Monetary Policy Report or press conference, but the statement will likely stress that policy will remain restrictive, with rates to be kept 'under review'.

"The key for markets will be the voting pattern among committee members. We are pencilling in another unprecedented three-way split, whereby one votes for a cut, two for a hike and the rest for no change. We see a distinct possibility, however, of a dovish swing, whereby one or both of the hawks shift their allegiance in favour of the majority. With markets not fully pricing in the first rate cut until August, this could pave the way for some weakness in sterling, as investors mull a start to easing at the bank's June meeting."

According to FXStreet cited consensus, the rate of consumer price inflation in the UK is forecast to have ebbed to 3.6% in February, from 4.0% in January.

The data is released at 0700 GMT. Before the Fed decision at 1800 GMT, Wednesday's economic calendar has a eurozone consumer confidence reading at 1500 GMT.

Against the yen, the dollar was trading at JPY150.76 at the time of the European equities close, jumping from JPY149.12.

In a long-anticipated move, the Bank of Japan on Tuesday ended its negative interest rate policy.

The Japanese central bank said it judged its monetary easing policy and yield curve control programme have "fulfilled their roles". It raised its short-term policy rate to a range of 0.0% to 0.1%, from minus 0.1% previously. The move marks the BoJ's first interest rate hike in 17 years.

XTB analyst Kathleen Brooks commented: "Right now, the market thinks that it could be one and done for the BoJ, however, with such large increases in wages, the BoJ could be forced into hiking again."

In the FTSE 100, Unilever rose 3.1%, after it said it plans to spin off its ice cream business and cut 7,500 jobs as it picks up the pace of its reorganisation plans.

The owner of Marmite, Dove soaps and Domestos announced the move alongside proposals to accelerate its "growth action plan".

Unilever intends to launch a comprehensive productivity programme which it anticipated will deliver total cost savings of around EUR800 million over the next three years, more than offsetting estimated operational dis-synergies from spinning off the ice cream business.

The changes are expected to impact around 7,500 jobs, with total restructuring costs now anticipated to be around 1.2% of group turnover for the next three years, up from around 1% of turnover previously guided.

Unilever, which owns five of the top 10 selling global ice cream brands including Wall's, Magnum and Ben & Jerry's, said the separation of ice cream will assist in the implementation of the GAP.

PureTech jumped 8.1%.

The Boston, Massachusetts-based biotherapeutics company said it plans to return USD100 million to shareholders with a tender offer, starting after it publishes its annual report in April.

Crest Nicholson slumped 9.1%, after it warned it could face a GBP15 million charge after uncovering defects in some legacy projects.

The Surrey, England-based housebuilder said the issues related to four sites that were completed prior to 2019 when the group closed its regeneration and London divisions.

Crest Nicholson said these sites will require remediation over the next three years at an estimated cost of up to GBP15 million.

Sofa retailer DFS fell 6.0%. It said pretax profit fell to GBP900,000 in the 26 weeks that ended December 24 from GBP6.8 million a year before, as revenue declined by 7.2% to GBP505.1 million from GBPP544.5 million.

In response, DFS cut its interim dividend by 27% to 1.1p from 1.5p.

Looking ahead, it lowered its financial 2024 adjusted pretax profit guidance to between GBP20 million and GBP25 million, which would be down from GBP30.6 million in financial 2023.

Revenue is expected to be between GBP1.00 billion and GBP1.02 billion, which would be down from GBP1.09 billion.

"After a solid start to January, market demand has weakened significantly over the last two months," DFS said, noting order volumes are down 16% on a year before.

Brent oil was quoted at USD87.19 a barrel late in London on Tuesday, up from USD86.27 late Monday. Gold fetched at USD2,155.26 an ounce on Tuesday, lower against USD2,158.93 late Monday.

Oil majors Shell and BP, among the FTSE 100's largest constituents, rose 1.3% and 1.0%. Conversely, gold miner Fresnillo fell 3.5%.

ActivTrades analyst Ricardo Evangelista commented: "The retreat in the precious metal's value is tied to the strengthening of the US dollar. This morning, the greenback reached a multi-week peak, signalling market anticipation of a hawkish stance from the Federal Reserve, potentially bolstering the dollar's standing. As the US central bank concludes its March meeting tomorrow, traders anticipate interest rates will remain unchanged. Nevertheless, persistent inflation and the robustness of the US economy suggest that the Fed may uphold its tight monetary policy for an extended period. In this context, the dollar's risk remains skewed to the upside, limiting the potential for gold price appreciation."

Wednesday's UK corporate calendar has annual results from insurer Prudential and a trading statement from financial services firm Investec.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
7 Oct 2022 07:10

Puretech Health confirms possible tie-up with Nektar Therapeutics

(Sharecast News) - PureTech Health said on Friday that it has exchanged indicative, non-binding proposals with US biopharmaceutical company Nektar Therapeutics regarding a possible combination.

Read more
5 Sep 2022 11:40

IN BRIEF: PureTech Health data on fibrosis drug candidate positive

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Posts positive data from a phase 1 trial of its idiopathic pulmonary fibrosis drug candidate LYT-100, or deupirfenidone.

Read more
31 Aug 2022 20:31

TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 19 after completing its quarterly review.

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 11:03

SMALL-CAP WINNERS & LOSERS: Hunting surges as loss narrows, ups payout

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

Read more
25 Aug 2022 10:10

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc.

Read more
25 Aug 2022 09:25

PureTech first-half mixed as it makes good clinical progress

(Sharecast News) - PureTech Health reported total first-half revenue of $7.03m on Thursday, up from $5.84m year-on-year.

Read more
24 Aug 2022 17:58

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds.

Read more
23 Aug 2022 18:14

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday.

Read more
22 Aug 2022 09:15

PureTech Health's Akili raises USD163 million via Nasdaq IPO

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children.

Read more
9 Aug 2022 09:31

PureTech gets USD115 million from sale of Karuna Therapeutics shares

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc.

Read more
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.